“Akeso-1”   

      Regulating Intestinal Microbial Balance

The "AKESO-1" supplement plays a crucial role in normalizing the microbial balance within the intestines. It efficiently accelerates the regeneration of anaerobic flora, including bifidobacteria and lactobacteria, while inhibiting the growth of potentially harmful microorganisms. Additionally, it enhances the activity of normal Escherichia coli, contributing to overall intestinal health.

Potent Antibacterial, Antibiotic, and Antimycotic Properties

Due to its fermentation process that leads to the production of lactic acid, lectoline, and lactocidine, "Akeso-1" exhibits formidable antibacterial activity. Experimental evidence supports its ability to suppress the growth of putrefactive and pus-producing microorganisms, such as Pseudomonas, E. coli, Kl. Pneumonia, Proteus Mirabilis, S. enteridis, S. gallinarum, S. Cholerae suis, S. Typhimurium, Shigella Serrata marcences, staphylococci, streptococci of L-form, and Candida albicans. Lactobacteria "Akeso-1" also prevents the permeability of pathogenic flora by establishing close contact with the intestinal mucous.

Immunomodulatory Function

Recent research has demonstrated that the "AKESO-1" drug stimulates the production of y- and a-interferon and enhances the activity of natural killer cells. In vitro experiments confirmed interferon production induced by "AKESO-1," showing its direct influence on blood and lymphatic cultures.

Stimulation of Vitamin and Lactic Acid Synthesis

Facilitation of Nutrient Absorption

"Akeso-1" facilitates the assimilation of essential nutrients such as calcium, phosphorus, vitamins, proteins, and carbohydrates.

Neutralization of Metabolic Toxins

The acido-lactic bacteria present in "Akeso-1" efficiently neutralize toxic metabolic by-products, including indole and skatole, rapidly eliminating them from the organism.

Antibiotic Resistance and Gastroenteric Adaptability

Acido-lactic bacteria exhibit resistance to antibiotics and other chemotherapeutic drugs, along with high adaptability within the gastroenteric tract.

Indications for Use:

·       Recommended for infants aged 6 months and older in liquid form as a nutritional supplement.

·       Beneficial in treating intestinal infections, dysbacteriosis, and post-antibiotic therapy.

·       Useful for clearing the body of toxins, combating premature aging, and alleviating discomfort after prolonged stress.

·       Normalizes intestinal function, addressing issues like constipation and diarrhea.

·       Acts as an immune-stimulator in viral and somatic diseases.

·       Effective in treating after-effects of radiation injuries, heavy metal poisoning, and industrial toxins.

·       Suitable for Helicobacter pylori-associated pathologies, liver disorders, chronic pancreatitis, gastroesophageal reflux, allergies, gynecologic diseases, and prophylaxis of nipple cracks and omphalitis.

Side Effects:

No registered side effects during the administration of "AKESO-1" probiotic.

Contraindications:

There are no absolute contraindications. Individuals with bovine milk allergies should explore alternative animal or non-animal milk sources for fermenting yogurt with "Akeso-1." Many find that even with cows milk allergies they can consume ASKESO-1 fermented in cows milk without issue. This should be introduced carefully and slowly to see individual reaction.

Forms of “AKESO-1”

“AKESO-1” Dry form of “AKESO-1” for practical shipping.

“AKESO-1”  has several advantages when shipped dry:

1.     The term of storage of the dry product is 2 years.

2.     High degree of transportability.

3.     Stability and exclusion of product spoilage.

4.     Large concentration of acido-lactic bacteria in small volume.

5.     Capsules containing AKESO-1 may be available at a later date.

6.     Fermented Akeso-1 Milk is easy to make from powdered starter.

Comparative characteristics of “AKESO-1” and other forms of fermented milk

Similar to "AKESO-1," various forms of fermented milk, including Kefir and others, exhibit distinct characteristics. The key features can be summarized as follows:

"AKESO-1" demonstrates a remarkable ability to stimulate the synthesis of vitamins and lactic acid in the organism, resulting in their swift absorption from the intestine. In contrast, Kefir lacks these properties.

The bacteria present in "AKESO-1" adapt to the human intestine for an extended period, leading to a prolonged therapeutic effect. Conversely, Kefir does not linger in the intestine for an extended duration.

Unlike Kefir, the bacteria in "AKESO-1" remain unaffected by the influence of antibiotics and chemotherapy drugs. This resilience allows "AKESO-1" to be safely used in combination with such medications.

The bactericidal effect of "AKESO-1" surpasses that of Kefir by 1.5 to 2 times, making it more effective in the therapy of various diseases. As a result, "AKESO-1" is employed in the treatment of numerous conditions, distinguishing it from the therapeutic use of Kefir.                                                                                                                                   

Table 1